Mithrl, which integrates its proprietary biomedical world model with the R&D systems of pharmaceutical companies, raised a $20M Series A led by Obvious Ventures (Natalie Breymeyer/Axios)
retained text
Techmeme permalink: https://www.techmeme.com/260920/p16#a260920p16 <a href="https://www.axios.com/pro/biotech-deals/2026/09/15/mithrl-series-a-biopharma-ai"><img align="RIGHT" border="0" hspace="4" src="http://www.techmeme.com/260920/i16.jpg" vspace="4" /></a> <p><a href="https://www.techmeme.com/260920/p16#a260920p16" title="Techmeme permalink"><img height="12" src="http://www.techmeme.com/img/pml.png" style="border: none; padding: 0; margin: 0;" width="11" /></a> Natalie Breymeyer / <a href="https://www.axios.com/">Axios</a>:<br /> <span style="font-size: 1.3em;"><b><a href="https://www.axios.com/pro/biotech-deals/2026/09/15/mithrl-series-a-biopharma-ai">Mithrl, which integrates its proprietary biomedical world model with the R&D systems of pharmaceutical companies, raised a $20M Series A led by Obvious Ventures</a></b></span> — Mithrl, an AI infrastructure company for biopharma, raised a $20 million Series A, CEO Vivek Adarsh tells Axios exclusively.</p>
document fetched 2026-09-21 02:40 · canonical https://axios.com/pro/biotech-deals/2026/09/15/mithrl-series-a-biopharma-ai